tiprankstipranks
Coherus Biosciences (CHRS)
NASDAQ:CHRS
Holding CHRS?
Track your performance easily

Coherus Biosciences (CHRS) Financial Statements

1,392 Followers

Coherus Biosciences Financial Overview

Coherus Biosciences's market cap is currently ―. The company's EPS TTM is $-0.1; its P/E ratio is -10.92; Coherus Biosciences is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 70.77M$ 64.98M$ 77.06M$ 91.52M$ 74.57M
Gross Profit$ 50.03M$ 36.61M$ 42.48M$ 6.96M$ 41.87M
EBIT$ -5.39M$ -7.59M$ 113.99M$ -69.03M$ -29.75M
EBITDA$ -3.84M$ -6.40M$ 115.50M$ -67.97M$ -28.85M
Net Income Common Stockholders$ -10.75M$ -12.89M$ 102.88M$ -79.65M$ -39.64M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 97.69M$ 159.24M$ 259.77M$ 117.75M$ 131.08M
Total Assets$ 505.00M$ 674.86M$ 763.54M$ 629.60M$ 583.78M
Total Debt$ 227.89M$ 227.56M$ 402.22M$ 226.89M$ 226.56M
Net Debt$ 130.20M$ 68.31M$ 142.44M$ 109.14M$ 95.48M
Total Liabilities$ 592.97M$ 758.96M$ 845.42M$ 823.03M$ 717.38M
Stockholders Equity$ -87.97M$ -84.11M$ -81.84M$ -193.43M$ -133.60M
Cash Flow-
Free Cash Flow$ -62.02M$ 59.73M$ 141.06M$ -12.97M$ -54.30M
Operating Cash Flow$ -62.02M$ 59.73M$ -46.77M$ -12.94M$ -54.30M
Investing Cash Flow$ 444.00K$ 27.66M$ 202.76M$ 35.20M$ 50.55M
Financing Cash Flow$ -167.00K$ -187.93M$ 887.00K$ 366.00K$ 11.11M
Currency in USD

Coherus Biosciences Earnings and Revenue History

Coherus Biosciences Debt to Assets

Coherus Biosciences Cash Flow

Coherus Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis